Marvell slides 3.9% as investors digest insider sale and recent AI-driven run-up

Marvell Technology, Inc. (MRVL) is down 3.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The pullback appears tied to profit-taking after Marvell’s sharp post-earnings rally earlier in March, alongside fresh attention on a CEO share sale disclosed in a recent SEC filing. Broader weakness in semiconductor and AI-infrastructure names also likely added pressure.

Details:

Marvell’s chairman and CEO reported selling 30,000 shares (about $3 million) on March 26, 2026, in a transaction described as executed under a pre-arranged Rule 10b5-1 trading plan.

The stock has been volatile in recent weeks following Marvell’s fiscal Q4 and full-year 2026 results and outlook update released on March 5, 2026, which drove a large upside move shortly afterward.

Chip stocks have recently traded with higher day-to-day sensitivity to AI spending expectations and risk-off sessions, and Marvell is often grouped with other data-center and AI supply-chain names.

This could also be a technical move: after a rapid advance, incremental negative headlines (even routine insider-plan sales) can trigger short-term de-risking.

Sources:

Marvell Investor Relations, Investing.com, Benzinga

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MRVL Insider Trading Activity

$MRVL insiders have traded $MRVL stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $MRVL stock by insiders over the last 6 months:

SANDEEP BHARATHI (President, Data Center Group) sold 44,414 shares for an estimated $4,424,078
MATTHEW J MURPHY (Chairman of the Board and CEO) sold 30,000 shares for an estimated $2,961,000
MARK CASPER (EVP & Chief Legal Officer) has made 0 purchases and 2 sales selling 6,253 shares for an estimated $591,953.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MRVL Hedge Fund Activity

We have seen 693 institutional investors add shares of $MRVL stock to their portfolio, and 762 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 28,510,714 shares (-77.7%) from their portfolio in Q4 2025, for an estimated $2,422,840,475
FMR LLC added 5,072,372 shares (+4.2%) to their portfolio in Q4 2025, for an estimated $431,050,172
BROWN ADVISORY INC removed 4,923,761 shares (-42.0%) from their portfolio in Q4 2025, for an estimated $418,421,209
MILLENNIUM MANAGEMENT LLC added 4,671,036 shares (+573.9%) to their portfolio in Q4 2025, for an estimated $396,944,639
ASPEX MANAGEMENT (HK) LTD removed 4,195,561 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $352,720,813
FIL LTD removed 3,703,901 shares (-29.2%) from their portfolio in Q4 2025, for an estimated $314,757,506
LAZARD ASSET MANAGEMENT LLC removed 3,473,448 shares (-54.3%) from their portfolio in Q4 2025, for an estimated $295,173,611

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MRVL Analyst Ratings

Wall Street analysts have issued reports on $MRVL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Rosenblatt issued a "Buy" rating on 02/03/2026
RBC Capital issued a "Outperform" rating on 01/15/2026
Melius Research issued a "Buy" rating on 01/05/2026
Susquehanna issued a "Positive" rating on 11/25/2025
UBS issued a "Buy" rating on 11/24/2025
Oppenheimer issued a "Outperform" rating on 10/10/2025

To track analyst ratings and price targets for $MRVL, check out Quiver Quantitative's $MRVL forecast page.

$MRVL Price Targets

Multiple analysts have issued price targets for $MRVL recently. We have seen 28 analysts offer price targets for $MRVL in the last 6 months, with a median target of $120.0.

Here are some recent targets:

Joshua Buchalter from TD Cowen set a target price of $90.0 on 03/06/2026
Harlan Sur from JP Morgan set a target price of $135.0 on 03/06/2026
Craig Ellis from B. Riley Securities set a target price of $135.0 on 03/06/2026
Srini Pajjuri from RBC Capital set a target price of $115.0 on 03/06/2026
Joseph Moore from Morgan Stanley set a target price of $103.0 on 03/06/2026
Kevin Cassidy from Rosenblatt set a target price of $140.0 on 03/06/2026
Vivek Arya from B of A Securities set a target price of $110.0 on 03/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.